Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment
Open Access
- 1 April 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 21 (4) , 918-922
- https://doi.org/10.1002/hep.1840210405
Abstract
Fourteen patients with chronic hepatitis C who had a sustained response to a 60-week interferon alfa-2b treatment course were followed, biochemically and virologically, 2 years after treatment cessation. Biopsies were repeated in 12 of 14 for histological and virological evaluation at 2-year follow-up. All 14 patients had normal serum alanine transaminase (s-ALT) levels and were negative for hepatitis C virus (HCV) RNA in serum during treatment and at short-term follow-up 6 months posttreatment. At 2-year follow-up, 13 patients still had normal ALT levels (<0.6 μkat/L for women; <0.8 μkat/L for men), 1 a near normal level (0.76 μkat/L); all were HCV RNA negative in serum, and 11 of 12 also in the liver. Liver histology improved during treatment and remained stable during the 2-year follow-up. The authors conclude that most sustained responders, who have normal ALT levels and are nonviremic at short-term follow-up 6 months after interferon treatment, will continue to have a durable long-term response without relapse of the viremia. (Hepatology 1995; 21:918-922.)Keywords
This publication has 26 references indexed in Scilit:
- Histological outcome in interferon alpha-2b treated patients with chronic posttransfusion non-A, non-B hepatitisLiver International, 2008
- Histological outcome in patients with chronic hepatitis C given a 60‐week interferon alfa‐2b treatment courseLiver International, 1994
- Hepatitis C RNA in liver of chronic hepatitis C patients before and after interferon alfa treatmentGastroenterology, 1993
- Detection of hepatitis C virus RNA by nested polymerase chain reaction in sera of patients with chronic non-A, non-B hepatitis treated with interferonJournal of Hepatology, 1992
- Decrease in Serum Hepatitis C Viral RNA during Alpha-Interferon Therapy for Chronic Hepatitis CAnnals of Internal Medicine, 1991
- Interferon for non-A, non-B chronic hepatitis: A meta-analysis of randomised clinical trialsJournal of Hepatology, 1991
- Application of a numerical scoring system for assessment of histological outcome in patients with chronic posttransfusion non‐A, non‐B hepatitis with or without antibodies to hepatitis CLiver International, 1990
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- A Randomized Controlled Open Study of Interferon Alpha-2b Treatment of Chronic IMon-A, Non-B Posttransfusion Hepatitis: No Correlation of Outcome to Presence of Hepatitis C Virus AntibodiesScandinavian Journal of Infectious Diseases, 1989